Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.

PHASE2UnknownINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

August 22, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions
Advanced Endometrial CancerSarcoma of Uterus
Interventions
DRUG

TQB2450 injection

TQB2450 is a humanized monoclonal antibody targeting programmed death ligand-1 (PD-L1), which prevents the binding of PD-L1 to PD-1 and B7.1 receptors on the surface of T cells, thereby reactivating T cells and enhancing the immune response.

DRUG

Anlotinib Hydrochloride Capsule

Anlotinib hydrochloride is a muti-target tyrosine kinase inhibitor.

DRUG

Carboplatin Injection

Carboplatin which s similar to alkylating agent, is a second-generation platinum anti-tumor drug, which mainly causes cross-linking of DNA within and between chains, destroys DNA molecules, and disintegrates the helix.

DRUG

Paclitaxel Injection

Paclitaxel is a diterpene alkaloid with anticancer activity

DRUG

Doxorubicin Hydrochloride Injection

Doxorubicin hydrochloride is a cycle non-specific anticancer chemotherapy drug, which directly acts on DNA, changes the nature of DNA template, and inhibits DNA polymerase.

DRUG

Gemcitabine Hydrochloride Injection

Gemcitabine is a cell cycle specific antimetabolic drug, which mainly acts on tumor cells at the DNA synthesis stage.

DRUG

Docetaxel injection

Docetaxel is an anti-tumor drug of paclitaxel, which plays an anti-tumor role by interfering with the microtubule network necessary for cell Mitosis and interphase cell function.

Trial Locations (11)

110801

RECRUITING

Liaoning Cancer Hospital & Institute, Shenyang

200090

RECRUITING

Obstetrics & Gynecology Hospital of Fudan University, Shanghai

225399

RECRUITING

Taizhou People's Hospital, Taizhou

250117

RECRUITING

Shandong Cancer Hospital, Jinan

264099

RECRUITING

Yantai Yuhuangding Hospital, Yantai

276002

RECRUITING

Linyi Cancer Hospital, Linyi

300181

RECRUITING

TianJin Medical University Cancer Institute & Hopspital, Tianjin

410013

RECRUITING

Hunan Cancer Hospital, Changsha

430062

RECRUITING

Zhongnan Hospital of Wuhan University, Wuhan

510120

RECRUITING

Sun Yat-sen Memorial Hospital, Guangzhou

710061

RECRUITING

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY